The underlying causes of chronic diarrhea beginning early in life are increasingly well defined. Infectious and post-infectious enteropathies and food sensitive/allergic enteropathy account for the majority of cases. Recent attention has focused on characterizing defined entities, which cause protracted diarrhea in infants and young children. Disorders of intestinal ion transport usually present at birth following a pregnancy complicated by polyhydramnios. Intestinal mucosal biopsies show normal architect with intact villus-crypt axis. Neonatal enteropathies, by contrast, are characterized by blunting of the villi. These include microvillus inclusion disease, tufting enteropathy, autoimmune enteropathy and IPEX syndrome -and it is these conditions that are the subject of the current review.
INTRODUCTION
Chronic and prolonged diarrhea is a symptom complex with a variety of underlying etiologies. A recent medical position statement, which was published by the American Gastroenterological Association (1), provides a comprehensive review of the subject in adults. However, a different approach is required for evaluating infants and young children with protracted diarrhea. The increasingly well-characterized enteropathies that present in the neonatal period or early infancy (2) provide the basis for this review.
Intractable diarrhea of infancy is a term coined many years ago by Avery (3) to describe chronic, unexplained diarrhea in young children. The phrase has since been decried because it describes a symptom complex rather than a discrete disease entity (4) . Protracted diarrhea has been used more recently as a generic term to describe infants with loose and frequent stools of sufficient severity to require nutritional support, often in the form of parenteral alimentation (5) . The emphasis on adequate support of total caloric intake and nutritional rehabilitation has dramatically improved the survival of affected infants and children.
Causes of protracted diarrhea beginning early in life can be divided into those entities having a normal villuscrypt axis and those associated with villus atrophy (Table  1) . Congenital defects in the transport of sodium, chloride, glucose/galactose and bile acids, and congenital enterokinase deficiency each can cause prolonged diarrhea dating to the early neonatal period (6) . Often, a maternal history of polyhydramnios during the pregnancy is a clue to the diagnosis. Stool collection for the determination of fecal electrolyte concentrations should be undertaken early on in the assessment because the results can prove helpful in identifying the underlying molecular defect (7) . In recent years, major advances have been made in understanding the molecular basis of these diseases (8, 9) .
The value of identifying an underlying etiology of chronic protracted diarrhea is that it allows improved counseling of parents, families, referring physicians and other health care professionals about long-term prognosis and therapeutic options (6) . In addition, since some of these conditions appear to have a genetic basis, the potential risk of subsequent affected siblings can be better assessed (10) .
Microvillus Inclusion Disease

Presentation
Microvillus inclusion disease is a severe enteropathy with watery diarrhea often beginning on the first day of life which is characterized on transmission electron microscopy by microvillus inclusions in enterocytes and colonocytes. This entity has been variously referred to as microvillus inclusion disease, congenital microvillus atrophy, familial microvillous atrophy and Davidson's syndrome (11) . We prefer the term microvillus inclusion disease because it highlights the characteristic diagnostic feature unique to this disorder, whereas microvillus atrophy is a non-specific finding observed in various types of intestinal injury.
In microvillus inclusion disease, diarrhea can be so watery that it is mistaken for urine. The fecal sodium and chloride concentrations approximate those of serum and the volume of stool loss may be equal to or greater than that observed during cholera infection. Ion flux studies demonstrate a net secretory state which accounts for the voluminous diarrhea (12) . As a result, affected infants will die of dehydration unless appropriate (often massive) intravenous fluid replacement is provided. Once infection has been excluded, microvillus inclusion disease is the most common identified cause of severe protracted diarrhea beginning during the first week of life (13) . In contrast to neonates with transport defects (for example, congenital chloride-losing diarrhea), polyhydramnios is not a common prenatal complication. Microvillus inclusion disease has been identified in infants from multiple ethnic backgrounds worldwide (14) . Multiple siblings can be affected (11) . The disease appears to cluster in infants of Navajo descent (15, 16) providing evidence in support of a genetic etiology.
Our experience indicates that classic microvillus inclusion disease is a severe and intractable enteropathy requiring total parenteral nutrition for the delivery of fluids and calories and that the condition is inevitably fatal without continuous intravenous nutrition or intestinal transplantation (13) . However, there are some reports of milder variants of microvillus inclusion disease that present later and in which the prognosis may be better (17) . Indeed, in some cases advancing enteral nutrition has been possible over time (18) .
Morphology
Duodenal biopsies in classic microvillus inclusion disease show normoplastic villus atrophy with relatively little crypt hyperplasia, and an absence of marked inflammatory infiltrate in the lamina propria (Figure 1 A) . On higher magnification, the surface enterocytes are focally piled-up and disorganized, with extensive vacuolization of the apical cytoplasm and loss of brush border definition (Figure 1 B) . As shown in Figure 1 C with periodic-acid Schiff (PAS) staining the apical brush border is poorly defined and there is PAS-positive staining of the apical cytoplasm of enterocytes that is not seen in normal small intestine (19) . Immunohistochemistry for brush border enzymes demonstrates the presence of alkaline phosphatase within the apical cytoplasm as well as in circular structures corresponding to microvillus inclusions (20) .
Immunostaining for various cytoplasmic and membrane antigens is useful in supporting the diagnosis of microvillus inclusion disease at the light microscope level. For example, immunostaining for villin, a microfilament component of the microvillus core, clearly demonstrates the intracytoplasmic microvillus inclusions (Figure1 D). Similarly, antibodies against carcinoembryonic antigen (CEA) and CD10, a leukemia antigen normally expressed in the brush border of enterocytes, are both useful in demonstrating microvillus inclusions (21, 22) . In cases of microvillus inclusion disease there is increased epithelial cell turnover with both enhanced proliferation (Ki67 staining) and increased programmed cell death (apoptosis detected by TUNEL assay) to levels higher than that observed in normal small bowel, but less than seen in gluten-sensitive enteropathy (23) .
The morphology of duodenal biopsies in the variant forms of microvillus inclusion disease is more variable and may evolve with time. In the reported cases (17) and in our experience (unpublished data), duodenal biopsies may initially show total villus atrophy, but later in life show relatively normal villi on routine histopathology (Figure 2 A) . However, in this setting PAS staining or immunostaining for CD10 will show patches of abnormal enterocytes containing microvillus inclusions next to apparently normal small bowel epithelium (Figure 2 B) .
On transmission electron microscopy, intracytoplasmic microvillus inclusions in surface epithelial cells are a characteristic and diagnostic feature of microvillus inclusion disease (Figure 3 A) because such inclusions are not found in other small bowel enteropathies (24, 25) . Microvillus inclusions can also be identified in colonocytes (26) and in epithelial cells lining the stomach, renal tubules (11) and gall bladder (12) . The classic microvillus inclusions are composed of complete brush borders with a microvillus membrane, microfilaments, the terminal web and a surface filamentous coat (Figure 3 B ). These microvillus inclusions are usually located close to the apical surface, but sometimes are found deeper in the cell cytoplasm without a clear membrane demarcation. Since microvillus inclusions are not found in every enterocyte, an extensive search on multiple blocks must be undertaken. Another common problem is inappropriate tissue orientation with lack of surface enterocytes evident in the sample viewed under transmission electron microscopy. When faced with these technical issues, it is possible to use formalin fixed, paraffin embedded tissues and re-process them for electron microscopy, as microvillus inclusions appear well preserved in such preparations (Figure 3 C).
The other characteristic electron microscopic feature of microvillus inclusion disease is the presence of apical secretory granules (also referred to as vesicular bodies). Vesicular bodies have a variable morphology but are usually composed of a single limiting membrane surrounding a lumen filled with a mixture of amorphous granular material, small vesicles and fragments of membranes. Vesicular bodies, which account for the vacuolated appearance and PAS-positive staining of enterocytes in microvillus inclusion disease, are prominent in surface epithelia, but are also found in cells lining the mid-and lower crypts (Figure 3 D) . A report of three cases describes the enterocytes which contain secretory granules, but which lack the classic microvillus inclusions (27) . It is possible that this unusual histology simply reflects a sampling bias since not every enterocyte will contain microvillus inclusions. 
Pathogenesis
The primary defect causing microvillus inclusion disease is not known. The occurrence among siblings has raised the possibility that it is a genetic defect inherited in an autosomal recessive manner (11, 13) . Speculation has focused on the assertion that the inclusions represent a genetic defect in the trafficking of membrane proteins to the apical surface of differentiated epithelia. It appears that the underlying defect is specifically related to the routing of constituents integral to the apical plasma membrane since cytoskeletal proteins tested are present and structurally intact (28) . Moreover, the insertion of transporters (eg. Na+-K+ATPase) into the basolateral membrane is also preserved (28, 29) .
Comparable inclusions in rat small bowel enterocytes are observed following enteral challenge with colchicine, an agent known to depolymerize and thereby disrupt the normal function of microtubules in the cell cytoplasm (30) . As in microvillus inclusion disease, delivery of proteins to the basolateral surface of rat enterocytes is not affected by treatment with pharmacologic agents used to impair the normal function of microtubules (30) . These findings suggest that disruption of the delivery of structurally intact constituents of the apical brush border membrane could account for the morphologic changes observed in microvillus inclusion disease (Figure 3 E) . Further studies to address this issue using human gut epithelia clearly are warranted.
A more recent study used immunogold electron microscopy on small bowel mucosa obtained from four children with microvillus inclusion disease to demonstrate sucrase-isomaltase hydrolase activity in the secretory granules present in crypt epithelia (31) . Microvillus inclusions were reported to correspond to early endosomes since they did not contain markers typical of lysosomes (eg. LAMP1, acid phosphatase). The authors concluded that autophagocytosis of the apical membrane of enterocytes accounted for the typical morphology, but did not identify the underlying defect that might promote such an aberrant response (31) . Of course, it is also conceivable that in microvillus inclusion disease the abnormal apical membrane of enterocytes resulting from a defect in the trafficking of membrane vesicles renders it more susceptible to autophagocytosis.
Currently, there are major advances being made in the study of the fundamental processes controlling cell differentiation, epithelial cell polarity, and intestinal epithelial response to injury (reviewed in 32, 33). It is anticipated that this knowledge will stimulate research aimed at identifying the basic defect causing microvillus inclusion disease.
Tufting Enteropathy
Presentation
Tufting enteropathy, also referred to as intestinal epithelial dysplasia, presents in the first few months of life with chronic watery diarrhea and impaired growth. Some affected infants are reported to have dysmorphic facial features (34) . The long-term prognosis is variable. Most affected individuals depend on parenteral alimentation to acquire a caloric intake sufficient for normal growth and development. However, a recent report describes a 27 year old patient with tufting enteropathy who delivered a normal child after an uncomplicated pregnancy (35) .
Morphology
Typical light microscopic findings in jejunal biopsies of infants with tufting enteropathy include total or partial villus atrophy, crypt hyperplasia and normal or slightly increased density of inflammatory cells in the lamina propria (Figure 4 A) . In contrast to celiac disease or autoimmune enteropathy, the number of intra-epithelial lymphocytes in tufting enteropathy is not markedly increased (11, 36) .
The characteristic feature of tufting enteropathy is the presence of focal epithelial "tufts" composed of closely packed enterocytes with rounding of the apical plasma membrane which results in a tear-drop configuration of the affected epithelial cell (Figure 4 B) . These morphologic changes may persist for years with some improvement in villus architecture on long-term follow-up (unpublished observations). In contrast with microvillus inclusion disease, PAS staining in tufting enteropathy shows a thin linear staining of the apical membrane surface without PAS positivity of the enterocyte cytoplasm (Figure 4 C) . On transmission electron microscopy, the cytoplasmic organelles of enterocytes appear well preserved. The brush border microvilli may be shortened, but there is an absence of microvillus inclusions or vesicular bodies (Figure 4 D ). An increase in the number and length of desmosomes between enterocytes forming the tufts has been reported (37) .
Pathogenesis
The molecular basis for tufting enteropathy is not known. There may be a primary genetic defect; support for such a contention is provided by the observation that many affected individuals are of Maltese ancestry and involved families can have many affected infants (36, 38) .
One case report of an infant with an underlying defect in the laying down of extracellular matrix (eg. altered laminin and changes in proteoglycan deposition) had some of the morphologic features of tufting enteropathy (38) . Epithelial cells lacking appropriate basement membrane are less well differentiated and subject to undergo programmed cell death (ie. apoptosis) (39, 40) . These changes may be related to a defect in the expression of cellular adhesion molecules. Patey et al. (37) altered distribution of alpha2/beta1 integrin and ultrastructural changes in desmosomes in the small bowel of six children with tufting enteropathy. A second case report describes deficient expression of alpha6/beta4 integrin in an infant with protracted diarrhea in whom epithelial cell detachment was observed in the stomach, small bowel and colon (41) . However, this report may possibly describe a child with another condition (epidermolysis bullosa associated with pyloric atresia) rather than tufting enteropathy (Alain Lachaux, Personal Communication).
A mouse model in which the gene encoding the transcription factor Elf3 is disrupted also has morphologic features compatible with tufting enteropathy in human infants (42) . In the mouse, there is abnormal morphogenesis of the villi from what appear to be intact progenitor cells in the crypts. The enterocytes in Elf3-deficient mice produce reduced levels of the transforming growth factor-beta type 2 receptor, which induces the differentiation of immature gut epithelia. Both the clinically based studies and the findings in experimental animals likely contain clues to the pathogenesis of tufting enteropathy that should be followed up in a careful, cooperative analysis of all cases identified at every center worldwide.
Autoimmune Enteropathy
Presentation
Cuenod et al. (43) summarized the clinical features of autoimmune enteropathy. They described 13 children with protracted diarrhea beginning during the first year of life whose intestinal mucosal biopsies showed villus atrophy and an infiltration of activated T cells into the lamina propria. In contrast to infants with microvillus inclusion disease and tufting enteropathy, those with autoimmune enteropathy frequently had extra-intestinal manifestations of autoimmunity. In addition, children with autoimmune enteropathy rarely had a family history of unexplained infant diarrhea. The onset of diarrhea frequently began after the first eight weeks of life and there was an apparent clinical response to potent immune suppression.
Morphology
Autoimmune enteropathy is characterized by a marked infiltration of activated T lymphocytes in the lamina propria of both the small and large intestinal lamina propria (44) . The histopathology is similar to celiac disease, except that there is a relative paucity of intraepithelial lymphocytes (43) . Furthermore, most of the affected infants have no history of gluten injestion before the onset of diarrhea (11) . In typical autoimmune enteropathy, duodenal biopsies show total villus atrophy, crypt hyperplasia and a dense lymphoplasmacytic infiltrate into the lamina propria (Figure 5 A) . Intraepithelial lymphocytes are present in both the surface and crypt epithelia ( Figure  5 B) . Crypt abscesses are identified in severely affected cases. The lesions are not confined to the small bowel; similar changes can be seen in the stomach and colon in some children. Immunohistochemistry shows up to a tenfold increase in CD3-positive lymphocytes within the epithelium and lamina propria (Figure 5 C) . The villus atrophy and crypt hyperplasia are both considered secondary features of an autoimmune-induced injury to the gut.
It is essential to exclude an underlying primary immune deficiency in infants considered to have autoimmune enteropathy. For instance, mutations in the gene encoding the CD3-gamma subunit of the T cell have been described in children with protracted diarrhea in infancy and features of autoimmunity (45) .
Pathogenesis
In infants with autoimmune enteropathy there is evidence of circulating systemic antibody against enterocytes. The autoantigen that the circulating antibody recognizes was initially not well defined, but investigators reported either a 55 kilodalton (46) or a 75 kilodalton protein (47, 48) . The autoantigen is encoded by a gene on chromosome 19p13 with homology to the tumor suppressor MCC (mutated in colon cancer) and, therefore, has been named MCC2 (49) . Circulating antibody is present in low titer and reacts against normal enterocytes from various animal species, including mice and rats, as well as human intestine. Antibody levels decline or disappear in response to immune suppression therapy and the titer may correlate with the volume of stool output.
In an apparently related condition, the autoantibody is directed against goblet cells. In case reports, the circulating antibody binds to mucins in goblet cells (50) . Histology of small bowel mucosa is characterized by an infiltration in the lamina propria of T cells accompanied by an absence of goblet cells, Paneth cells and enteroendocrine cells (50) . In contrast to what is generally reported in autoimmune enteropathy, the surface epithelial cells in this condition are relatively intact. It is possible that this defect, which appears to involve secretory cell lineages, is a result of a defect in Math1 transcription factor. Math1 null mice demonstrate an absence of goblet, Paneth, and enteroendocrine cells while the enterocyte lineage is preserved (51).
IPEX Syndrome
Presentation & Morphology
IPEX refers to a condition characterized by immune dysregulation, polyendocrinopathy, enteropathy and X-linkage. The syndrome has many intestinal manifestations in common with autoimmune enteropathy, including villus atrophy with a marked infiltration into the lamina propria of activated T cells.
Pathogenesis
The underlying genetic basis of the IPEX syndrome is a mutation of the FOXP3 gene (52, 53) . FOXP3, also referred to as scurfin, is a transcription factor involved in the proliferation of CD4+ T cells (54) . The central role of FOXP3 in the development of regulatory T cells has been highlighted recently (55, 56) . Children considered to have autoimmune enteropathy who develop insulindependent diabetes mellitus, thyroid disease, eczematous ichthyosis or hemolytic anemia or who have a similarly effected sibling should be carefully tested for the FOXP3 mutation. A previous reports of brothers with unexplained protracted diarrhea beginning in early infancy and a number of circulating autoantibodies, including anti-enterocyte antibody (57), must be considered potentially to have mutations in the FOXP3 gene.
Therapeutic Considerations
Nutritional support and provision of adequate hydration is of paramount importance to ensure optimal growth and development. Measurement of urine volume and urine sodium losses can prove helpful in ensuring sufficient fluid intake to maintain intravascular volume. For severely affected children, total parenteral nutrition must be instituted early. Dissecting the underlying etiology and providing targeted therapy should await nutritional rehabilitation. In other instances where there is less severe involvement of the gut, the use of elemental or low carbohydrate-containing formula can promote enteral delivery of calories and nutrients thereby avoiding the complications associated with parenteral alimentation (58) .
Medications, including antisecretory agents (59,60) and trophic factors (61) success. For autoimmune enteropathies, immune suppressive agents -including corticosteroids, cyclosporine (62, 63) , tacrolimus (64) , infliximab (65), cyclophosphamide (66) and mycophenolate mofetil (67) -have been used with apparent benefit. In infants with microvillus inclusion disease and tufting enteropathy these options are usually unsuccessful and the long-term prognosis is more guarded. As a result, small bowel transplantation has been undertaken in these settings with promising results in a limited number of subjects (68, 69) . Isolated small bowel (70, 71) and combined liver-intestinal transplantation (72, 73) both have been successfully used in the management of children with microvillus inclusion disease.
For children with IPEX syndrome, a recent report indicates that allogeneic bone marrow transplant can be curative (74) . Whether similar benefit can be obtained in a subset of severely affected patients with autoimmune enteropathy unresponsive to potent immune suppression should be determined in a carefully controlled clinical research setting. Development of an appropriate animal model would be of great benefit in determining the utility of bone marrow transplantation for affected infants and children.
Conclusions & Future Directions
A concerted effort to define the molecular bases of microvillus inclusion disease, tufting enteropathy and autoimmune enteropathy is urgently required. This approach is ultimately much more likely to provide for rational therapy and appropriate prenatal testing compared with the empiric approach that has been undertaken to date. Given the low prevalence of these disorders, it is likely that a multicenter and multinational initiative -similar to the approach currently being taken to elucidate the etiology of inflammatory bowel diseases (75) -will be required to advance the field. No doubt, there are additional disease entities that cause protracted diarrhea in infants and young children awaiting description and definition. It is disappointing that so little progress has been made to date in undertaking genome-wide scanning in affected patients, their siblings and parents. An initiative led by the National Institutes for Health, or comparable funding agency, likely will be necessary (75) . Affected children, their families and caretakers deserve no less.
